It’s year four in our mission to lead the charge in brain cancer survival.
Driven by charitable support and shared purpose, our goal is to create exponential change in brain cancer survival by building an elite research community and accelerating implementation of life-sustaining treatments.
ReMission Summit is a workshop for leading brain tumor researchers and clinicians, industry innovators, and government neuro-oncology experts. Sponsored by University of Florida Trustee Anita Zucker and Orlando Businessman, Harris Rosen, and organized by leading neuro-oncology researcher Duane A. Mitchell, MD, PhD, this summit joins forces across disciplines, institutions, and the usual borders that all too often stymie effective research.
The ReMission Summit will focus on the latest advances in targeted immunotherapy approaches for the treatment of adult and pediatric brain tumors and outline the unanswered questions, challenges, and opportunities that lay ahead for advancing the duration and quality of life for patients with brain tumors.
Launched in 2019 as the inaugural gathering of an annual event, the ReMission Summit will chart a course for transformative progress over the next decade and track progress toward milestone-driven objectives outlined by the leading experts in the field.